Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
Condition:   Dry Eye Disease Interventions:   Drug: glycerin 0.7%/PEG 400 0.3%;   Drug: polyethylene glycol 400 0.4%/propylene glycol 0.3% Sponsors:   Calm Water Therapeutics LLC;   Andover Research Eye Institute Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials